ARS Pharmaceuticals Files for Approval of Experimental Allergic Reaction Treatment in Canada, UK

MT NewswiresJan 7 00:06

Institutional Investors May Overlook ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) Recent US$56m Market Cap Drop as Long-term Gains Remain Positive

Simply Wall StDec 31, 2024 21:02

ARS Pharmaceuticals Says Express Scripts Has Added Neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies

BenzingaDec 20, 2024 06:29

ARS Pharmaceuticals Announces Neffy (Epinephrine Nasal Spray) Is Available on Express Scripts Commercial National Formularies

GlobeNewswireDec 20, 2024 06:25

ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 18, 2024 21:00

ARS Pharmaceuticals Files For Approval Of Neffy In China, Japan And Australia

BenzingaDec 13, 2024 03:35